Literature DB >> 31152241

Interlaboratory Variability in Human Hepatocyte Intrinsic Clearance Values and Trends with Physicochemical Properties.

Christine M Bowman1, Leslie Z Benet2.   

Abstract

PURPOSE: To examine the interlaboratory variability in CLint values generated with human hepatocytes and determine trends in variability and clearance prediction accuracy using physicochemical and pharmacokinetic parameters.
METHODS: Data for 50 compounds from 14 papers were compiled with physicochemical and pharmacokinetic parameter values taken from various sources.
RESULTS: Coefficients of variation were as high as 99.8% for individual compounds and variation was not dependent on the number of prediction values included in the analysis. When examining median values, it appeared that compounds with a lower number of rotatable bonds had more variability. When examining prediction uniformity, those compounds with uniform in vivo underpredictions had higher CLint, in vivo values, while those with non-uniform predictions typically had lower CLint, in vivo values. Of the compounds with uniform predictions, only a small number were uniformly predicted accurately. Based on this limited dataset, less lipophilic, lower intrinsic clearance, and lower protein binding compounds yield more accurate clearance predictions.
CONCLUSIONS: Caution should be taken when compiling in vitro CLint values from different laboratories as variations in experimental procedures (such as extent of shaking during incubation) may yield different predictions for the same compound. The majority of compounds with uniform in vitro values had predictions that were inaccurate, emphasizing the need for a better mechanistic understanding of IVIVE. The non-uniform predictions, often with low turnover compounds, reaffirmed the experimental challenges for drugs in this clearance range. Separating new chemical entities by lipophilicity, intrinsic clearance, and protein binding may help instill more confidence in IVIVE predictions.

Entities:  

Keywords:  hepatocytes; in vitro-in vivo extrapolation; intrinsic clearance; variability

Mesh:

Substances:

Year:  2019        PMID: 31152241      PMCID: PMC7191673          DOI: 10.1007/s11095-019-2645-0

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  35 in total

1.  Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption.

Authors:  D E Clark
Journal:  J Pharm Sci       Date:  1999-08       Impact factor: 3.534

2.  In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance.

Authors:  M G Soars; B Burchell; R J Riley
Journal:  J Pharmacol Exp Ther       Date:  2002-04       Impact factor: 4.030

3.  Practical use of the regression offset approach for the prediction of in vivo intrinsic clearance from hepatocytes.

Authors:  Anna-Karin Sohlenius-Sternbeck; Christopher Jones; Douglas Ferguson; Brian J Middleton; Denis Projean; Eva Floby; Johan Bylund; Lovisa Afzelius
Journal:  Xenobiotica       Date:  2012-04-18       Impact factor: 1.908

Review 4.  BDDCS Predictions, Self-Correcting Aspects of BDDCS Assignments, BDDCS Assignment Corrections, and Classification for more than 175 Additional Drugs.

Authors:  Chelsea M Hosey; Rosa Chan; Leslie Z Benet
Journal:  AAPS J       Date:  2015-11-20       Impact factor: 4.009

5.  Comparison of intrinsic clearances in human liver microsomes and suspended hepatocytes from the same donor livers: clearance-dependent relationship and implications for prediction of in vivo clearance.

Authors:  Joanne A Foster; J Brian Houston; David Hallifax
Journal:  Xenobiotica       Date:  2010-11-09       Impact factor: 1.908

6.  Molecular properties that influence the oral bioavailability of drug candidates.

Authors:  Daniel F Veber; Stephen R Johnson; Hung-Yuan Cheng; Brian R Smith; Keith W Ward; Kenneth D Kopple
Journal:  J Med Chem       Date:  2002-06-06       Impact factor: 7.446

7.  A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes.

Authors:  Robert J Riley; D F McGinnity; R P Austin
Journal:  Drug Metab Dispos       Date:  2005-06-02       Impact factor: 3.922

8.  A practical and direct comparison of intrinsic metabolic clearance of several non-CYP enzyme substrates in freshly isolated and cryopreserved hepatocytes.

Authors:  Takafumi Akabane; Nicolas Gerst; Yoichi Naritomi; Jeffrey N Masters; Kouichi Tamura
Journal:  Drug Metab Pharmacokinet       Date:  2011-10-25       Impact factor: 3.614

9.  The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data.

Authors:  R S Obach; J G Baxter; T E Liston; B M Silber; B C Jones; F MacIntyre; D J Rance; P Wastall
Journal:  J Pharmacol Exp Ther       Date:  1997-10       Impact factor: 4.030

10.  Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.

Authors:  R Scott Obach; Franco Lombardo; Nigel J Waters
Journal:  Drug Metab Dispos       Date:  2008-04-21       Impact factor: 3.922

View more
  6 in total

1.  Physiologically based pharmacokinetic (PBPK) modelling of tamsulosin related to CYP2D6*10 allele.

Authors:  Pureum Kang; Hye-Jung Park; Chang-Keun Cho; Yun Jeong Lee; Jung-Woo Bae; Choon-Gon Jang; Seok-Yong Lee
Journal:  Arch Pharm Res       Date:  2021-11-09       Impact factor: 4.946

2.  Prediction of hepatic drug clearance with a human microfluidic four-cell liver acinus microphysiology system.

Authors:  Courtney Sakolish; Yu-Syuan Luo; Alan Valdiviezo; Lawrence A Vernetti; Ivan Rusyn; Weihsueh A Chiu
Journal:  Toxicology       Date:  2021-09-17       Impact factor: 4.221

3.  Investigating the Theoretical Basis for In Vitro-In Vivo Extrapolation (IVIVE) in Predicting Drug Metabolic Clearance and Proposing Future Experimental Pathways.

Authors:  Leslie Z Benet; Jasleen K Sodhi
Journal:  AAPS J       Date:  2020-09-10       Impact factor: 4.009

Review 4.  Successful and Unsuccessful Prediction of Human Hepatic Clearance for Lead Optimization.

Authors:  Jasleen K Sodhi; Leslie Z Benet
Journal:  J Med Chem       Date:  2021-03-25       Impact factor: 7.446

5.  SirT3 activates AMPK-related mitochondrial biogenesis and ameliorates sepsis-induced myocardial injury.

Authors:  Ting Xin; Chengzhi Lu
Journal:  Aging (Albany NY)       Date:  2020-07-28       Impact factor: 5.682

6.  AMPKα2 Overexpression Reduces Cardiomyocyte Ischemia-Reperfusion Injury Through Normalization of Mitochondrial Dynamics.

Authors:  Yuanyan Deng; Sainan Chen; Mingming Zhang; Chen Li; Jing He; Ying Tan
Journal:  Front Cell Dev Biol       Date:  2020-08-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.